Management Sciences for Health

Call Directions Website Contact the organization

Management Sciences for Health MSH advances knowledge and technology globally to support people locally to achieve health for all.

MSH takes an integrated approach to building high-impact sustainable programs that address critical challenges in leadership, health systems management, health service delivery, human resources, and medicines. Wherever our partnerships succeed, the positive impact of good health has a ripple effect, contributing to the building of healthy nations. MSH works collaboratively with health care policymakers, managers, providers, and the private sector to increase the efficacy, efficiency, and sustainability of health services by improving management systems, promoting access to services, and influencing public policy.

Global health has entered a period of tighter resources, higher expectations, and greater pressure for countries to sust...
10/14/2026

Global health has entered a period of tighter resources, higher expectations, and greater pressure for countries to sustain progress with less reliance on traditional development assistance.

For Management Sciences for Health (MSH), that reinforces a direction we have been building toward for years: stronger country leadership, stronger institutions, and health systems designed to last.

Our latest Annual Report reflects that evolution.

MSH pairs more than five decades of global experience with country-rooted delivery, working alongside governments and communities to strengthen financing, institutions, health workforces, medicines and supply systems, and the use of data for better decisions.

We are also sharpening where MSH adds distinctive value: combining deep implementation experience with stronger advisory capabilities in financing, governance, institutional strengthening, and systems transformation.

The model may be evolving, but the goal remains: helping countries strengthen the capacity, ownership, and systems needed to improve health over the long term. Explore MSH’s Annual Report: https://msh.org/annual-report/

What keeps essential medicines moving when conditions change? It takes more than a functioning warehouse or a well-stock...
10/13/2026

What keeps essential medicines moving when conditions change? It takes more than a functioning warehouse or a well-stocked pharmacy.

Strong supply chains depend on the systems behind them: good planning, reliable data, sustainable financing, effective procurement, and local capacity to make decisions and adapt. This matters most when systems are under pressure.

In , MSH is working to strengthen the national supply chain so essential medicines and health products can reach communities, including those hardest to serve.

In , strengthening national procurement and medicines reimbursement systems is helping maintain access to essential medicines amid the disruption of war.

These experiences point to a broader lesson: supply chains are a core part of health system capacity. Their resilience depends on whether the institutions, policies, financing, data, and people behind them can work together and adapt when circumstances change. Building that capability is essential to keeping care moving.

Learn more about MSH’s work to strengthen supply chain and pharmaceutical systems: https://msh.org/resources/strengthening-supply-chain-and-pharmaceutical-systems-for-sustained-health-impact/

now has a fully operational digital tool to strengthen how antiretroviral (ARV) medicine needs are forecast and planne...
10/12/2026

now has a fully operational digital tool to strengthen how antiretroviral (ARV) medicine needs are forecast and planned.

The tool enables standardized, data-driven quantification of antiretroviral medicines at the national, regional, and healthcare facility levels, using patient, treatment, stock, delivery, and epidemiological data. This supports more precise supply planning and helps maintain continuity of antiretroviral therapy.

The tool is now ready for routine ARV forecasting and planning, strengthening Ukraine’s capacity for evidence-based demand planning and more sustainable medicines supply management.

The “Safe, Affordable, and Effective Medicines for Ukrainians” (SAFEMed) Activity, funded by the U.S. Government, provided technical and expert support throughout the development process, working with the Center for Public Health and Medical Procurement of Ukraine to refine the tool, prepare users, and support its transition into routine use.

Read the full story in the latest SAFEMed Monthly News Digest: https://msh.org/resources/august-2026-monthly-newsletter-safemed-activity/

Rebecca Kohler

In , millions of people remain beyond the reach of essential health services, in part because community health workers ...
10/12/2026

In , millions of people remain beyond the reach of essential health services, in part because community health workers are insufficient in number and unevenly distributed.

In partnership with Mastercard Foundation, MSH is working alongside national and state governments to reskill and upskill 44,000 community health workers across 17 states. The Community Health Workforce Program (CHWP) strengthens digital tools, institutional capacity, and government-led structures to support quality care over time.

A stronger health workforce needs strong systems behind it. Read more in MSH’s 2025 Annual Report: https://msh.org/annual-report/

’s medicines market has remained resilient through four years of full-scale war, reaching an estimated $4.6 billion in ...
10/06/2026

’s medicines market has remained resilient through four years of full-scale war, reaching an estimated $4.6 billion in 2026. But new pressures are emerging.

Retail medicine sales fell 9% in volume in January–April 2026 as household purchasing power weakened, even as government financing of medicines continued to grow. At the same time, the market faces significant supply-chain concentration, with two distributors supplying roughly 75% of the retail market.

The new report by the Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity, funded by the U.S. Government, Resilience Under Pressure: Ukraine’s Medicines Market, 2022–2026, examines these pressures alongside the strengths that continue to support the market. It also highlights opportunities for Ukraine to strengthen domestic pharmaceutical production and attract investment as the country moves toward recovery.

Read the full report and explore what the findings mean for the future of Ukraine’s medicines market: https://msh.org/resources/safemed-reports-ukraines-pharmaceutical-market-shows-resilience-amid-war-with-new-risks-and-opportunities-emerging/

Rebecca Kohler

"Nine years is a significant milestone, but it does not feel like a finish line.”As the “Safe, Affordable, and Effective...
09/30/2026

"Nine years is a significant milestone, but it does not feel like a finish line.”

As the “Safe, Affordable, and Effective Medicines for Ukrainians” (SAFEMed) Activity, funded by the U.S. Government, marks nine years of work in Ukraine, Rebecca Kohler, MPH, SAFEMed Chief of Party, reflects on her time with the Activity and the changes she has witnessed across ’s health system.

From seeing new institutions take shape and reforms move from ideas to practice to witnessing the health system adapt through the COVID-19 pandemic and Russia’s full-scale invasion, Rebecca looks back with a sense of pride and gratitude. She also reflects on what the foundations built over these nine years can mean for Ukraine’s future.

Read Rebecca’s full reflection and explore the latest SAFEMed results in the Monthly News Digest: https://msh.org/resources/safemed-reports-ukraines-pharmaceutical-market-shows-resilience-amid-war-with-new-risks-and-opportunities-emerging/

09/29/2026

A medicine missing from a clinic is not always a stock problem.

The gap may begin much earlier—with forecasting, procurement, financing, data, distribution, or the systems responsible for getting products where they are needed.

That is why MSH’s work on medicines and supply chains goes beyond moving commodities. We work with governments to strengthen the systems behind reliable access.

In , MSH worked with the Ethiopian Pharmaceutical Supply Service, regional health bureaus, and local transport providers to maintain deliveries to nearly 1,000 facilities across conflict-affected regions. In the final quarter of 2025, $8.7 million in HIV, TB, malaria, and maternal health commodities reached more than 1.3 million people. MSH has also supported national efforts to assess supply-chain maturity and strengthen procurement practices.

In , more than 15 years of partnership with the Ministry of Health have helped strengthen pharmaceutical and procurement systems that continue to support access to medicines during wartime. Since 2018, centralized procurement reforms have generated more than $259 million in savings.

These are the systems behind the medicines that reach patients, and the systems countries need to sustain access over time. Explore MSH’s work: https://msh.org/annual-report/

An outcome of the ministerial and partner dialogue convened by Africa CDC and Management Sciences for Health on the marg...
09/25/2026

An outcome of the ministerial and partner dialogue convened by Africa CDC and Management Sciences for Health on the margins of :

Government leaders from , , , , and came together with Africa CDC and global health partners around a shared imperative: pandemic prevention, preparedness, and response must be rooted in stronger, country-led health systems.

The dialogue centered the experience and priorities of countries navigating both immediate health threats and the longer-term work of building resilient institutions, sustainable financing, strong primary and community health systems, capable health workforces, and reliable access to medicines and supplies.

Alongside Africa CDC and Management Sciences for Health, the discussion included MINISTERE DE LA SANTE DU Benin, Ministry of Health Kenya, Federal Ministry of Health and Social Welfare Nigeria, government leaders from and , and partners from the Financing Alliance for Health, Gavi, the Vaccine Alliance, The Global Fund, Pandemic Fund, UNICEF, Unitaid, and World Health Organization (WHO) African Region.

Now, Africa CDC and Management Sciences for Health are calling on Member States and partners to take these priorities forward—at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response and through the national, regional, and global decisions that follow.

The Africa CDC–MSH Call to Action on Pandemic Prevention, Preparedness and Response sets out concrete priorities for turning this shared commitment into action.

We invite governments and partners to read it, share it, and help carry these priorities forward.

🔗:https://msh.org/wp-content/uploads/2026/09/Africa-CDC-and-MSH_Call-to-Action_PPPR.pdf

09/23/2026

At , Africa CDC and Management Sciences for Health (MSH) will convene leaders and experts to discuss how stronger, more resilient health systems can advance pandemic preparedness, prevention and response (PPPR).

H.E. Dr. Jean Kaseya, Director General of Africa CDC, will deliver remarks alongside Marian W. Wentworth, President and CEO of MSH.

📅 24 September 2026
🕛 12:00–2:00 PM
📍 New York City

The conversation will bring together government leaders from Kenya, Nigeria, Rwanda, Uganda and beyond, followed by a high-level expert dialogue on global health and financing.

Pandemic preparedness cannot sit apart from the health systems countries rely on every day.Readiness is built through in...
09/23/2026

Pandemic preparedness cannot sit apart from the health systems countries rely on every day.

Readiness is built through institutions that can plan and finance a response, health workers who are equipped to act, supply chains that can move essential products, and primary health care and community systems that can continue delivering when a crisis hits.

That is also what makes preparedness sustainable: embedding it in national priorities, budgets, and institutions rather than rebuilding capacity each time a new threat emerges.

Tomorrow at , Africa CDC and Management Sciences for Health will bring together government and global health leaders to discuss what this looks like in practice — and what needs to change in how preparedness is financed, led, and supported.

If you are attending , connect with the delegation and join the conversation: https://msh.org/story/beyond-panic-and-neglect-the-role-of-health-systems-in-pandemic-prevention-preparedness-and-response/

Address

Allston, MA

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Telephone

+16172509500

Website

Alerts

Be the first to know and let us send you an email when Management Sciences for Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Management Sciences for Health:

Shortcuts

Share

Category